Indian Stock Market News | BSE/NSE Sensex Updates | Equity Market Highlights

Market Highlights

Get the latest Indian stock / share market highlights, BSE/NSE stock news, business research reports & details - updated daily by Money Times.

July 23, 2025

Daily Morning Report Date: 23rd July 2025
NIFTY OUTLOOK: 25060.90 FII: -Rs. 3548.92 cr | DII: Rs. 5239.77 cr
As discussed yesterday, the market behaved on expected lines. Nifty opened on a positive note, moved up to our resistance level of 25182 but failed to sustain, and slipped down to our support zone of 25045 (day’s low: 25035), finally settling at 25060.90.
An average bearish candle on the daily chart now suggests that bulls are losing grip while bears are gaining strength. If selling pressure persists and Nifty breaks decisively below 25016, it may drift lower towards 24973–24927. Further downside could open the door for a test of 24883.
On the upside, 25108–25150 remains the immediate resistance zone. A breakout and sustained move above this range may push the index further towards 25193–25239.
Bank Nifty Outlook:
Spot: 56756.00 | PCR: 0.75 Max Call OI: 57000 | Max Put OI: 56000
On 22nd July 2025, Bank Nifty closed at 56756.00, down 0.35% from the previous session. The index witnessed a total intraday movement of 594.15 points, making a high of 57286.15 and a low of 56692.00.
Technical View – Daily Chart:
Key support is placed at 56500, while resistance is seen around 57300.
Intraday Trading Strategy:
Long above 57150 with a stop loss of 56860 and target of 57080.
Short below 56590 with a stop loss of 56640 and target of 56420.
RSI Analysis:
The Relative Strength Index (RSI) stands at 51.50 — indicating a neutral zone (below 30 is oversold, above 70 is overbought).
SMA Overview
Trading above 5 out of 8 Simple Moving Averages (30, 50, 100, 150, 200-Day).
Trading below 3 out of 8 SMAs (5, 10, 20-Day).
No active candlestick pattern identified on the daily chart.
Macros .
1. Dollar index @ 97.16
2. S&P 500 vix @ 16.50
3. Brent crude @ 68.77
4. US 10 years bond yield @ 4.354
Note:
A lot of developments are taking place on the trade deal front.
A major trade deal has been sealed between Japan and the U.S. President Donald Trump on Wednesday said his administration had completed a “massive deal” with Japan, which will see the Asian country subject to a 15% tariff on exports.
In his speech, Federal Reserve Chairman Jerome Powell emphasized a politically independent Fed policy, as tensions grow between the White House and the Fed regarding rate cuts. The President again stated that Powell will be out in eight months and called him "numb." The relationship between the White House and the Fed has hit an all-time low. This suggests that Trump is desperate for a rate cut, and the Fed is being pressured to act sooner rather than later.
India is also expected to sign a trade deal with the UK during Prime Minister Narendra Modi’s visit. According to officials, India and Britain will sign a Free Trade Agreement on Thursday. As part of the deal, India will ease tariffs on British whisky, cars, and select food items, while the UK will offer duty-free access to Indian textiles and electric vehicles.
On the commodities front, bullion prices hit an all-time high in the Indian market and a five-week high in international markets, driven by softer bond yields and the Dollar Index. Crude continues to hover around $70 despite ongoing issues in the Middle East—primarily due to uncertainties surrounding tariffs.
Contributed by
Ashok bhandari : INH000019549
-------------------------------------xxxxxxx-------------------------------------------------------------------xxxxxxx---------------------------------
Schloss (The Leela) Management says Should Have ₹400 Cr PAT By FY28
Will See Margin To Sustain Between 49-50%
Did Well In Q1 Despite Headwinds, Business Has Been Resilient In July
International Tourists Currently Around 50%; Pre-Covid Was In The Range Of 65-75%
@beatthestreet10
Biocon : Co. Launches Biosimilar Nepexto® in Australia
Global Expansion: Launch of Nepexto® (biosimilar to Enbrel®) marks entry into Australian market.
Local Partnership: Product to be promoted by Generic Health, strengthening Biocon’s regional presence.
Therapeutic Focus: Targets autoimmune conditions like rheumatoid arthritis and psoriasis.
Proven Track Record: Already approved and adopted in EU since 2020, enhancing credibility.
Strategic Growth: Strengthens Biocon's immunology portfolio and global biosimilar footprint.
Hero MotoCorp : Co. Launches New HF Deluxe Pro to Strengthen Entry-Level Portfolio
Positive Impact
New Launch: Hero MotoCorp unveils the HF Deluxe Pro, enhancing its HF Deluxe lineup.
Segment-Focused: Targets entry-level commuters with best-in-class mileage and new-age features.
Key Features:
i3S (Idle Stop-Start System)
Low-friction engine, advanced tyres
LED headlamp with crown-shaped position lamp
Horizon digital console with real-time data
Design Upgrade: Bold graphics, chrome accents, and contemporary styling appeal to young riders.
Affordable Pricing: Priced at ₹73,550 (ex-showroom Delhi), ensuring strong value proposition.
Impact: Positive for Hero MotoCorp’s volume growth, rural penetration, and entry-level dominance.
@beatthestreet10
Inox Wind : Co. Bags 51 MW Order from First Energy (Thermax Group)
Positive Impact
First Order from FEPL (Thermax Group): Marks the beginning of a new client relationship.
51 MW Wind Project: Supply of 3 MW turbines for Tamil Nadu-based project.
Includes EPC & Multi-Year O&M Services: Provides long-term revenue visibility.
Strengthens C&I Renewable Segment Presence: Expands footprint in the fast-growing commercial & industrial renewable energy market.
Boosts Inox Group Ecosystem: Supports EPC, manufacturing, and O&M subsidiaries.
Supports Energy Transition: Aligned with India’s renewable energy goals.
@beatthestreet10
CG CONSUMER: Crompton Achieves Zero-Debt Milestone After Rs. 300 Cr Final NCD Repayment
Positive Impact
Completed Rs. 300 Cr final NCD repayment, totaling Rs. 2,125 Cr for Butterfly Gandhimathi acquisition.
Now net cash positive, achieving zero-debt status.
Reduces interest burden, allowing more funds for growth & innovation.
Reflects strong cash flow generation and efficient financial management.
Reinforces long-term value creation and shareholder confidence.
@beatthestreet10
ETERNAL; Fll limit will remain an overhang; MSCI outflows seen - NDTV PROFIT
Short Term Negatives -
As of Jun-25, FPI holding was 42.8%, which will result in MSCI weight cut in Aug
Foreign shareholding above 46.5% would result in inclusion in FPI Red flag list & will be reported daily by exchanges
FPI holding above 47.65% will result in total MSCI exclusion
Foreign holding at 49.5% would restrict FPI buying, but selling would be permitted
@beatthestreet10
MACROTECH; Large Trade: 99.51 lk shares (1% eq) change hands at ₹1,386/sh
@beatthestreet10
OBEROI REALTY: Large Trade: 1.11 cr shares (3.1% eq) change hands at ₹1,762/sh
@beatthestreet10
MCX : MCX TRADING HALTED
As Of Now Market Is Halted, Expected To Start By 9.45 AM
@beatthestreet10
Phoenix Mills : Company denies rumours of acquiring McLeod Russel by Ruias, calling them baseless and misleading.
Clarification issued to ensure transparency and compliance with SEBI regulations.
Company confirms there are no ongoing deals or discussions regarding the rumour.
Statement follows viral speculation circulating on social media platforms.
@beatthestreet10
KEI Industries : Management reaffirms goal to increase export contribution to 20% of total sales within 2–3 years.
Company maintains FY26 full-year revenue growth guidance of 18–20%.
Adopts a cautious outlook while sticking to its existing growth targets, as per CNBC-TV18.
@beatthestreet10
Blue Jet : Management expects gross margin to normalise in the next quarter.
EBITDA margin is projected to remain in the mid-thirties range.
Company remains confident that profits will align with historical performance, according to NDTV Profit.
@beatthestreet10
Whirlpool : EQT and Bain Capital are in the final race to acquire a 31% controlling stake in Whirlpool of India, as per ET.
TPG, KKR, Havells, and Reliance have exited the bidding process.
Binding offers are expected by August 2025.
Deal could bring strategic support and operational changes post-acquisition.
@beatthestreet10
NLC India : Management says it is exploring opportunities in mining rare earth minerals, according to NDTV Profit.
The company has secured two critical mineral blocks in Chhattisgarh.
It has set a target of producing 1 million metric tonnes of critical minerals by 2030.
@beatthestreet10
Dixon Tech : Management expects margins this year to remain at similar levels as last year.
Order book appears strong for Q2, supporting near-term performance.
Laptops are projected to contribute meaningfully from next year onwards.
Full-year revenue growth is estimated at 40–45%.
@beatthestreet10
NLC INDIA : NIRL, the renewable energy arm of the company, plans to launch a ₹4000 crore IPO in Q2FY27.
The IPO proceeds will partly fund its green energy expansion, targeting 10 GW capacity by 2030.
NIRL aims to file its draft red herring prospectus (DRHP) with SEBI in Q1FY27.
Due diligence for the listing is expected to be completed by March 2026.
@beatthestreet10
NLC INDIA Management says Need Capex Of ₹50,000 Cr For The Target Of Producing 10 GW
@beatthestreet10
DIXON management says Will Be Getting Into Automotive Display In Next Couple Of Years
JV With Signify Will Be Operational First Week Of Aug'25 Onwards - CNBC-TV18
@beatthestreet10
DIXON management says Mobiles Followed By Telecom Will Lead Revenue Mix In FY26
@beatthestreet10
KEI IND : Management expects domestic market share to remain stable going forward.
Government and private sector capex are both witnessing healthy growth.
Company aims to improve EBITDA margin by 0.5% to 1% through operational efficiencies.
@beatthestreet10
Sigachi : Co. to launch new R&D center in Hyderabad on 28th July 2025 for high-value API development.
Focus areas include diabetes, anticoagulants, heart failure, cholesterol, and allergy treatments.
Team of 32–35 scientists to lead lab-to-commercial innovation and regulatory filings.
Move strengthens backward integration and global pharma competitiveness.
@beatthestreet10

First

Last